{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:07:05Z","timestamp":1789265225806,"version":"build-2803163510"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100016299","name":"Al-Ahliyya Amman University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016299","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"DOI":"10.1007\/s12033-026-01611-z","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T14:04:23Z","timestamp":1789221863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantifying HER-2 for Precision Oncology: The Role of Optical Biosensors"],"prefix":"10.1007","author":[{"given":"Qamar","family":"Abuhassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5573-4875","authenticated-orcid":false,"given":"Jamal I.","family":"Al-Nabulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pareshkumar N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. V.","family":"Jamuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya Priyadarshini","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin Kumar","family":"Tailor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dildora","family":"Turaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"issue":"6","key":"1611_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.4103\/ijdr.IJDR_534_16","volume":"28","author":"P Rajaram","year":"2017","unstructured":"Rajaram, P., Chandra, P., Ticku, S., Pallavi, B. K., Rudresh, K. B., & Mansabdar, P. (2017). Epidermal growth factor receptor: Role in human cancer. Indian Journal of Dental Research, 28(6), 687\u2013694.","journal-title":"Indian Journal of Dental Research"},{"issue":"Supplement_1","key":"1611_CR2","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1677\/erc.1.01032","volume":"12","author":"L Bazley","year":"2005","unstructured":"Bazley, L., & Gullick, W. J. J. (2005). The epidermal growth factor receptor family. Endocrine-Related Cancer, 12(Supplement_1), S17\u2013S27.","journal-title":"Endocrine-Related Cancer"},{"key":"1611_CR3","doi-asserted-by":"publisher","first-page":"496832","DOI":"10.3389\/fonc.2019.01308","volume":"9","author":"C Arienti","year":"2019","unstructured":"Arienti, C., Pignatta, S., & Tesei, A. (2019). Epidermal growth factor receptor family and its role in gastric cancer. Frontiers in oncology, 9, 496832.","journal-title":"Frontiers in oncology"},{"issue":"9","key":"1611_CR4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.5858\/arpa.2023-0950-SA","volume":"147","author":"AC Wolff","year":"2023","unstructured":"Wolff, A. C., Somerfield, M. R., Dowsett, M., Hammond, M. E. H., Hayes, D. F., McShane, L. M., Saphner, T. J., Spears, P. A., & Allison, K. H. (2023). Human epidermal growth factor receptor 2 testing in breast cancer. Archives of pathology & laboratory medicine, 147(9), 993\u20131000.","journal-title":"Archives of pathology & laboratory medicine"},{"issue":"1","key":"1611_CR5","doi-asserted-by":"publisher","first-page":"7992","DOI":"10.1038\/s41598-024-57515-y","volume":"14","author":"Y-N Kim","year":"2024","unstructured":"Kim, Y.-N., Chung, Y. S., Park, E., Lee, S. T., & Lee, J.-Y.J. (2024). Human epidermal growth factor receptor-2 expression and subsequent dynamic changes in patients with ovarian cancer. Scientific Reports, 14(1), 7992.","journal-title":"Scientific Reports"},{"issue":"12","key":"1611_CR6","doi-asserted-by":"publisher","first-page":"030006052413072","DOI":"10.1177\/03000605241307217","volume":"52","author":"TA Hamdan","year":"2024","unstructured":"Hamdan, T. A., Alkhateeb, S., Oriquat, G., Alzoubi, A., & Ahmed, K. A. A. (2024). Impact of breastfeeding and formula feeding on immune cell populations and blood cell parameters: An observational study. Journal of International Medical Research, 52(12), 03000605241307217.","journal-title":"Journal of International Medical Research"},{"issue":"1-2","key":"1611_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/rpd\/ncu243","volume":"162","author":"S Radenkovic","year":"2014","unstructured":"Radenkovic, S., Konjevic, G., Isakovic, A., Stevanovic, P., Gopcevic, K., & Jurisic, V. (2014). HER2-positive breast cancer patients: Correlation between mammographic and pathological findings. Radiation Protection Dosimetry, 162(1\u20132), 125\u2013128.","journal-title":"Radiation Protection Dosimetry"},{"issue":"3","key":"1611_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41571-023-00849-9","volume":"21","author":"A Marra","year":"2024","unstructured":"Marra, A., Chandarlapaty, S., & Modi, S. J. (2024). Management of patients with advanced-stage HER2-positive breast cancer: Current evidence and future perspectives. Nature Reviews Clinical Oncology, 21(3), 185\u2013202.","journal-title":"Nature Reviews Clinical Oncology"},{"key":"1611_CR9","doi-asserted-by":"publisher","first-page":"119946","DOI":"10.1016\/j.cca.2024.119946","volume":"564","author":"S Rouhi","year":"2025","unstructured":"Rouhi, S., Ghasemi, H., Alizadeh, M., Movahedpour, A., Vahedi, F., Fattahi, M., et al. (2025). MiRNA-based electrochemical biosensors for ovarian cancer. Clinica Chimica Acta, 564, 119946.","journal-title":"Clinica Chimica Acta"},{"key":"1611_CR10","doi-asserted-by":"publisher","first-page":"117792","DOI":"10.1016\/j.cca.2024.117792","volume":"555","author":"MR Abdul Wahab","year":"2024","unstructured":"Abdul Wahab, M. R., Palaniyandi, T., Viswanathan, S., Baskar, G., Surendran, H., Gangadharan, S. G. D., et al. (2024). Biomarker-specific biosensors revolutionise breast cancer diagnosis. Clinica Chimica Acta, 555, 117792.","journal-title":"Clinica Chimica Acta"},{"key":"1611_CR11","doi-asserted-by":"publisher","first-page":"104246","DOI":"10.1016\/j.pdpdt.2024.104246","volume":"48","author":"ZKS McOtshana","year":"2024","unstructured":"McOtshana, Z. K. S., Thwala, L. N., Tlomatsane, M. H. C., van Steen, E., & Mthunzi-Kufa, P. (2024). Recent advances in the development of multiplexed nanophotonic biosensors. Photodiagnosis and Photodynamic Therapy, 48, 104246.","journal-title":"Photodiagnosis and Photodynamic Therapy"},{"key":"1611_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1201\/9781003334859-8","volume-title":"Food safety","author":"P Nath","year":"2024","unstructured":"Nath, P., Dhewa, T., & Kumar, S. (2024). Assessment of biological contaminants by using ELISA\/PCR technique. Food safety (pp. 131\u2013150). CRC Press."},{"issue":"7","key":"1611_CR13","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/bios15070434","volume":"15","author":"H-B Jeon","year":"2025","unstructured":"Jeon, H.-B., Song, D.-Y., Park, Y. J., & Kim, D.-M.J.B. (2025). Enhancing ELISA sensitivity: From surface engineering to synthetic biology. Biosensors, 15(7), 434.","journal-title":"Biosensors"},{"issue":"9","key":"1611_CR14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/14789450.2020.1845654","volume":"17","author":"V Jurisic","year":"2020","unstructured":"Jurisic, V. (2020). Multiomic analysis of cytokines in immuno-oncology. Expert Review of Proteomics, 17(9), 663\u2013674.","journal-title":"Expert Review of Proteomics"},{"key":"1611_CR15","first-page":"119984","volume":"565","author":"ZO Roudsari","year":"2025","unstructured":"Roudsari, Z. O., Khoramrooz, S. S., Rouhi, S., Ghasem, H., Khatami, S. H., Alizadeh, M., et al. (2025). Electrochemical and optical biosensors for the detection of E. Coli., 565, 119984.","journal-title":"Coli."},{"key":"1611_CR16","doi-asserted-by":"publisher","first-page":"103906","DOI":"10.1016\/j.pdpdt.2023.103906","volume":"45","author":"SH Chauke","year":"2024","unstructured":"Chauke, S. H., Nzuza, S., Ombinda-Lemboumba, S., Abrahamse, H., Dube, F. S., & Mthunzi-Kufa, P. (2024). Advances in the detection and diagnosis of tuberculosis using optical-based devices. Photodiagnosis and Photodynamic Therapy, 45, 103906.","journal-title":"Photodiagnosis and Photodynamic Therapy"},{"issue":"2","key":"1611_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/35052073","volume":"2","author":"Y Yarden","year":"2001","unstructured":"Yarden, Y., & Sliwkowski, M. X. (2001). Untangling the ErbB signalling network. Nature reviews Molecular cell biology, 2(2), 127\u2013137.","journal-title":"Nature reviews Molecular cell biology"},{"issue":"4717","key":"1611_CR18","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1126\/science.2992090","volume":"229","author":"AL Schechter","year":"1985","unstructured":"Schechter, A. L., Hung, M. C., Vaidyanathan, L., Weinberg, R. A., Yang-Feng, T. L., Francke, U., et al. (1985). The neu gene: An erb B-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science, 229(4717), 976\u2013978.","journal-title":"Science"},{"key":"1611_CR19","doi-asserted-by":"crossref","unstructured":"Tafe LJ, Tsongalis GJ (2013). The human epidermal growth factor receptor 2 (HER2)","DOI":"10.1007\/978-1-4614-8127-0_3"},{"key":"1611_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pep.2015.09.001","volume":"125","author":"S Kanthala","year":"2016","unstructured":"Kanthala, S., Mill, C. P., Riese, I. I. D. J., Jaiswal, M., & Jois, S. J. (2016). Expression and purification of HER2 extracellular domain proteins in Schneider2 insect cells. Protein Expression and Purification, 125, 26\u201333.","journal-title":"Protein Expression and Purification"},{"issue":"22","key":"1611_CR21","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1200\/JCO.22.02864","volume":"41","author":"AC Wolff","year":"2023","unstructured":"Wolff, A. C., Somerfield, M. R., Dowsett, M., Hammond, M. E. H., Hayes, D. F., McShane, L. M., et al. (2023). Human epidermal growth factor receptor 2 testing in breast cancer: ASCO\u2013College of American pathologists guideline update. Journal of Clinical Oncology, 41(22), 3867\u20133872.","journal-title":"Journal of Clinical Oncology"},{"issue":"29","key":"1611_CR22","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1200\/JCO.22.01002","volume":"40","author":"HS Rugo","year":"2022","unstructured":"Rugo, H. S., Bardia, A., Marm\u00e9, F., Cortes, J., Schmid, P., Loirat, D., et al. (2022). Sacituzumab govitecan in hormone receptor\u2013positive\/human epidermal growth factor receptor 2\u2013negative metastatic breast cancer. Journal of Clinical Oncology, 40(29), 3365\u20133376.","journal-title":"Journal of Clinical Oncology"},{"key":"1611_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.actbio.2021.08.055","volume":"135","author":"SJ Kim","year":"2021","unstructured":"Kim, S. J., Dixon, A. S., & Owen, S. C. J. A. B. (2021). Split-enzyme immunoassay to monitor EGFR-HER2 heterodimerization on cell surfaces. Acta Biomaterialia, 135, 225\u2013233.","journal-title":"Acta Biomaterialia"},{"issue":"25","key":"1611_CR24","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1200\/JCO.21.02772","volume":"40","author":"J Huober","year":"2022","unstructured":"Huober, J., Barrios, C. H., Niikura, N., Jarz\u0105b, M., Chang, Y. C., Huggins-Puhalla, S. L., et al. (2022). Atezolizumab with neoadjuvant anti\u2013human epidermal growth factor receptor 2 therapy and chemotherapy in human epidermal growth factor receptor 2\u2013positive early breast cancer: Primary results of the randomized phase III IMpassion050 trial. Journal of Clinical Oncology, 40(25), 2946\u20132956.","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"1611_CR25","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3390\/genes15070903","volume":"15","author":"X Cheng","year":"2024","unstructured":"Cheng, X. (2024). A comprehensive review of HER2 in cancer biology and therapeutics. Genes, 15(7), 903.","journal-title":"Genes"},{"issue":"10087","key":"1611_CR26","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","volume":"389","author":"S Loibl","year":"2017","unstructured":"Loibl, S., & Gianni, L. (2017). HER2-positive breast cancer. The Lancet, 389(10087), 2415\u20132429.","journal-title":"The Lancet"},{"issue":"9","key":"1611_CR27","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1093\/annonc\/mdn169","volume":"19","author":"C Gr\u00e1valos","year":"2008","unstructured":"Gr\u00e1valos, C., & Jimeno, A. (2008). HER2 in gastric cancer: A new prognostic factor and a novel therapeutic target. Annals of Oncology, 19(9), 1523\u20131529.","journal-title":"Annals of Oncology"},{"issue":"4","key":"1611_CR28","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.3390\/ijms24043720","volume":"24","author":"F Sanguedolce","year":"2023","unstructured":"Sanguedolce, F., Zanelli, M., Palicelli, A., Bisagni, A., Zizzo, M., Ascani, S., et al. (2023). HER2 expression in bladder cancer: A focused view on its diagnostic, prognostic, and predictive role. International Journal of Molecular Sciences, 24(4), 3720.","journal-title":"International Journal of Molecular Sciences"},{"key":"1611_CR29","doi-asserted-by":"publisher","first-page":"693394","DOI":"10.3389\/fonc.2021.693394","volume":"11","author":"K Egebjerg","year":"2021","unstructured":"Egebjerg, K., Harwood, C. D., Woller, N. C., Kristensen, C. A., & Mau-S\u00f8rensen, M. (2021). HER2 positivity in histological subtypes of salivary gland carcinoma: A systematic review and meta-analysis. Frontiers in Oncology, 11, 693394.","journal-title":"Frontiers in Oncology"},{"issue":"24","key":"1611_CR30","doi-asserted-by":"publisher","first-page":"6517","DOI":"10.1158\/1078-0432.CCR-14-1647","volume":"20","author":"JW Groeneweg","year":"2014","unstructured":"Groeneweg, J. W., Hernandez, S. F., Byron, V. F., DiGloria, C. M., Lopez, H., Scialabba, V., et al. (2014). Dual HER2 targeting impedes growth of HER2 gene-amplified uterine serous carcinoma xenografts. Clinical Cancer Research, 20(24), 6517\u20136528.","journal-title":"Clinical Cancer Research"},{"issue":"22","key":"1611_CR31","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.3390\/cancers17223672","volume":"17","author":"E Carvalho","year":"2025","unstructured":"Carvalho, E., Schmitt, F., & Vale, N. (2025). Interplay between microRNAs and breast cancer therapies: Personalized therapeutic potential for HER2-low breast cancer. Cancers, 17(22), 3672.","journal-title":"Cancers"},{"key":"1611_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.breast.2017.01.010","volume":"32","author":"C Jackisch","year":"2017","unstructured":"Jackisch, C., Lammers, P., & Jacobs, I. (2017). Evolving landscape of human epidermal growth factor receptor 2-positive breast cancer treatment and the future of biosimilars. The Breast, 32, 199\u2013216.","journal-title":"The Breast"},{"issue":"2","key":"1611_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","volume":"22","author":"SM Swain","year":"2023","unstructured":"Swain, S. M., Shastry, M., & Hamilton, E. (2023). Targeting HER2-positive breast cancer: Advances and future directions. Nature Reviews Drug Discovery, 22(2), 101\u2013126.","journal-title":"Nature Reviews Drug Discovery"},{"issue":"15","key":"1611_CR34","doi-asserted-by":"publisher","first-page":"7285","DOI":"10.3390\/ijms26157285","volume":"26","author":"M Ratti","year":"2025","unstructured":"Ratti, M., Citterio, C., Orlandi, E., Vecchia, S., Anselmi, E., Toscani, I., et al. (2025). Fighting HER2 in gastric cancer: Current approaches and future landscapes. International Journal of Molecular Sciences, 26(15), 7285.","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"1611_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/jso.23456","volume":"109","author":"SB Fisher","year":"2014","unstructured":"Fisher, S. B., Fisher, K. E., Squires, M. H., III., Patel, S. H., Kooby, D. A., El-Rayes, B. F., et al. (2014). HER2 in resected gastric cancer: Is there prognostic value? Journal of Surgical Oncology, 109(2), 61\u201366.","journal-title":"Journal of Surgical Oncology"},{"issue":"9","key":"1611_CR36","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1093\/annonc\/mdt232","volume":"24","author":"WQ Sheng","year":"2013","unstructured":"Sheng, W. Q., Huang, D., Ying, J. M., Lu, N., Wu, H. M., Liu, Y. H., et al. (2013). HER2 status in gastric cancers: A retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significance. Annals of Oncology, 24(9), 2360\u20132364.","journal-title":"Annals of Oncology"},{"issue":"14","key":"1611_CR37","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.3390\/jcm12144646","volume":"12","author":"Y Sato","year":"2023","unstructured":"Sato, Y., Okamoto, K., Kawano, Y., Kasai, A., Kawaguchi, T., Sagawa, T., et al. (2023). Novel biomarkers of gastric cancer: Current research and future perspectives. Journal of Clinical Medicine, 12(14), 4646.","journal-title":"Journal of Clinical Medicine"},{"issue":"7","key":"1611_CR38","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1038\/s41591-024-02992-x","volume":"30","author":"K Shitara","year":"2024","unstructured":"Shitara, K., Bang, Y. J., Iwasa, S., Sugimoto, N., Ryu, M. H., Sakai, D., et al. (2024). Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: Exploratory biomarker analysis of the randomized, phase 2 DESTINY-Gastric01 trial. Nature medicine, 30(7), 1933\u20131942.","journal-title":"Nature medicine"},{"issue":"10","key":"1611_CR39","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3390\/medicina61101759","volume":"61","author":"E Kraevska","year":"2025","unstructured":"Kraevska, E., & Popovska, S. J. M. (2025). Analysis of HER2 expression in different histological subtypes and IHC-based molecular variants of muscle-invasive bladder carcinoma. Medicina, 61(10), 1759.","journal-title":"Medicina"},{"issue":"10","key":"1611_CR40","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41585-023-00773-8","volume":"20","author":"M Maas","year":"2023","unstructured":"Maas, M., Todenh\u00f6fer, T., & Black, P. C. J. N. R. U. (2023). Urine biomarkers in bladder cancer\u2014current status and future perspectives. Nature Reviews Urology, 20(10), 597\u2013614.","journal-title":"Nature Reviews Urology"},{"key":"1611_CR41","doi-asserted-by":"publisher","first-page":"1591191","DOI":"10.3389\/fimmu.2025.1591191","volume":"16","author":"F Zhang","year":"2025","unstructured":"Zhang, F., & Li, S. (2025). Antibody-drug conjugates as game changers in bladder cancer: Current progress and future directions. Frontiers in Immunology, 16, 1591191.","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"1611_CR42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41585-025-01075-x","volume":"23","author":"D Raggi","year":"2026","unstructured":"Raggi, D., Crupi, E., Pederzoli, F., Martini, A., Briganti, A., Alhalabi, O., et al. (2026). HER2 and urothelial carcinoma: Current understanding and future directions. Nature Reviews Urology, 23(2), 110\u2013132.","journal-title":"Nature Reviews Urology"},{"key":"1611_CR43","doi-asserted-by":"publisher","first-page":"106612","DOI":"10.1016\/j.oraloncology.2023.106612","volume":"148","author":"DM Filippini","year":"2024","unstructured":"Filippini, D. M., Pagani, R., Tober, N., Lorini, L., Riefolo, M., Molinari, G., et al. (2024). HER2-targeted therapies for salivary gland cancers. Oral Oncology, 148, 106612.","journal-title":"Oral Oncology"},{"key":"1611_CR44","doi-asserted-by":"publisher","first-page":"102697","DOI":"10.1016\/j.ctrv.2024.102697","volume":"124","author":"L Rached","year":"2024","unstructured":"Rached, L., Saleh, K., Casiraghi, O., & Even, C. (2024). Salivary gland carcinoma: Towards a more personalised approach. Cancer Treatment Reviews, 124, 102697.","journal-title":"Cancer Treatment Reviews"},{"issue":"5","key":"1611_CR45","doi-asserted-by":"publisher","first-page":"528","DOI":"10.21873\/cdp.10250","volume":"3","author":"V Papanikolaou","year":"2023","unstructured":"Papanikolaou, V., Chrysovergis, A., D Asimakopoulos, A., Spyropoulou, D., Ragos, V., Papanastasiou, G., et al. (2023). Impact of amplified oncogenes on salivary gland carcinomas. Cancer Diagnosis & Prognosis, 3(5), 528.","journal-title":"Cancer Diagnosis & Prognosis"},{"issue":"9","key":"1611_CR46","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1634\/theoncologist.2015-0149","volume":"20","author":"EJ Diver","year":"2015","unstructured":"Diver, E. J., Foster, R., Rueda, B. R., & Growdon, W. B. J. T. O. (2015). The therapeutic challenge of targeting HER2 in endometrial cancer. The Oncologist, 20(9), 1058\u20131068.","journal-title":"The Oncologist"},{"issue":"2","key":"1611_CR47","first-page":"e70024","volume":"11","author":"DO Macaulay","year":"2025","unstructured":"Macaulay, D. O., Han, W., Zarella, M. D., Garcia, C. A., & Tavolara, T. E. J. T. J. P. C. R. (2025). Enhancing HER2 testing in breast cancer: Predicting fluorescence in situ hybridization (FISH) scores from immunohistochemistry images via deep learning. The Journal of Pathology: Clinical Research, 11(2), e70024.","journal-title":"The Journal of Pathology: Clinical Research"},{"key":"1611_CR48","unstructured":"Molteni E (2025). HER2 evaluation from tissue to liquid biopsy: Improving CTC HER2 characterization for clinical implementation in breast cancer"},{"issue":"1","key":"1611_CR49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.5114\/pjp.2014.42672","volume":"65","author":"M Colovi\u0107","year":"2014","unstructured":"Colovi\u0107, M., Todorovi\u0107, M., Colovi\u0107, N., Terzic, T., Karadzic, K., & Juri\u0161i\u0107, V. (2014). Appearance of estrogen positive bilateral breast carcinoma with HER2 gene amplification in a patient with aplastic anemia. Polish Journal of Pathology\u202f: Official Journal of the Polish Society of Pathologists., 65(1), 66\u201369.","journal-title":"Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists."},{"key":"1611_CR50","unstructured":"Girigoswami K, Akhtar NJ (2019). Nanobiosensors and fluorescence based biosensors: An overview. 10(1):1-17"},{"issue":"5","key":"1611_CR51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/toxins10050197","volume":"10","author":"A Sharma","year":"2018","unstructured":"Sharma, A., Khan, R., Catanante, G., Sherazi, T. A., Bhand, S., Hayat, A., & Marty, J. L. (2018). Designed strategies for fluorescence-based biosensors for the detection of mycotoxins. Toxins, 10(5), 197.","journal-title":"Toxins"},{"issue":"1","key":"1611_CR52","doi-asserted-by":"publisher","first-page":"2300519","DOI":"10.1002\/biot.202300519","volume":"19","author":"R Goodrum","year":"2024","unstructured":"Goodrum, R., & Li, H. (2024). Advances in three dimensional metal enhanced fluorescence based biosensors using metal nanomaterial and nano-patterned surfaces. Biotechnology Journal, 19(1), 2300519.","journal-title":"Biotechnology Journal"},{"key":"1611_CR53","doi-asserted-by":"publisher","first-page":"e200403","DOI":"10.2903\/j.efsa.2022.e200403","volume":"20","author":"MV Barbieri","year":"2022","unstructured":"Barbieri, M. V., Rodrigues, A. C., & Febbraio, F. (2022). Monitoring of pesticide amount in water and drinkable food by a fluorescence-based biosensor. EFSA Journal, 20, e200403.","journal-title":"EFSA Journal"},{"issue":"11","key":"1611_CR54","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.3390\/s23115053","volume":"23","author":"P Nath","year":"2023","unstructured":"Nath, P., Mahtaba, K. R., & Ray, A. (2023). Fluorescence-based portable assays for detection of biological and chemical analytes. Sensors, 23(11), 5053.","journal-title":"Sensors"},{"issue":"8","key":"1611_CR55","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/diagnostics13081375","volume":"13","author":"AK Verma","year":"2023","unstructured":"Verma, A. K., Noumani, A., Yadav, A. K., & Solanki, P. R. (2023). FRET based biosensor: Principle applications recent advances and challenges. Diagnostics, 13(8), 1375.","journal-title":"Diagnostics"},{"issue":"27","key":"1611_CR56","doi-asserted-by":"publisher","first-page":"21479","DOI":"10.1039\/D5RA01942G","volume":"15","author":"MR Ibrahim","year":"2025","unstructured":"Ibrahim, M. R., Alneyadi, S., Truong, K.-N., El-Maghraby, H., Abdellah, M., El-Zohry, A. M., et al. (2025). Design of a Zn-based porphyrin MOF biosensor for fluorometric detection of HER2 as a breast cancer biomarker. RSC Advances., 15(27), 21479\u201321492.","journal-title":"RSC Advances."},{"key":"1611_CR57","doi-asserted-by":"publisher","first-page":"106300","DOI":"10.1016\/j.microc.2021.106300","volume":"167","author":"SY Digehsaraei","year":"2021","unstructured":"Digehsaraei, S. Y., Salouti, M., Amini, B., Mahmazi, S., Kalantari, M., Kazemizadeh, A., et al. (2021). Developing a fluorescence immunosensor for detection of HER2-positive breast cancer based on graphene and magnetic nanoparticles. Microchemical Journal, 167, 106300.","journal-title":"Microchemical Journal"},{"key":"1611_CR58","doi-asserted-by":"publisher","first-page":"109426","DOI":"10.1016\/j.microc.2023.109426","volume":"195","author":"N Li","year":"2023","unstructured":"Li, N., Zhang, Y., Xu, Y., Liu, X., Yang, Z., Wang, Q., et al. (2023). An ultra-sensitive fluorescent aptamer sensor based on 2D MOF for detection of HER2 in serum. Microchemical Journal, 195, 109426.","journal-title":"Microchemical Journal"},{"key":"1611_CR59","doi-asserted-by":"publisher","first-page":"115374","DOI":"10.1016\/j.ab.2023.115374","volume":"684","author":"T Pileri","year":"2024","unstructured":"Pileri, T., Sinibaldi, A., Occhicone, A., Danz, N., Giordani, E., Allegretti, M., et al. (2024). Direct competitive assay for HER2 detection in human plasma using Bloch surface wave-based biosensors. Analytical Biochemistry, 684, 115374.","journal-title":"Analytical Biochemistry"},{"issue":"14","key":"1611_CR60","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1007\/s00216-020-02643-3","volume":"412","author":"A Sinibaldi","year":"2020","unstructured":"Sinibaldi, A., Doricchi, A., Pileri, T., Allegretti, M., Danz, N., Munzert, P., et al. (2020). Bioassay engineering: A combined label-free and fluorescence approach to optimize HER2 detection in complex biological media. Analytical and Bioanalytical Chemistry, 412(14), 3509\u20133517.","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"37","key":"1611_CR61","doi-asserted-by":"publisher","first-page":"23718","DOI":"10.1021\/acsomega.0c02578","volume":"5","author":"S-i Tanaka","year":"2020","unstructured":"Tanaka, S.-i, Wadati, H., Sato, K., Yasuda, H., & Niioka, H. J. A. O. (2020). Red-fluorescent Pt nanoclusters for detecting and imaging HER2 in breast cancer cells. ACS Omega, 5(37), 23718\u201323723.","journal-title":"ACS Omega"},{"key":"1611_CR62","doi-asserted-by":"publisher","first-page":"150747","DOI":"10.1016\/j.bbrc.2024.150747","volume":"734","author":"E Shramova","year":"2024","unstructured":"Shramova, E., Frolova, A. Y., Serova, E., Deyev, S., & Proshkina, G. (2024). A novel HER2-specific sensor based on DARPin_9\u201329 and albumin binding domain for real-time fluorescence-guided tumor detection in animal model of cancer. Biochemical and Biophysical Research Communications, 734, 150747.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"1611_CR63","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13550-018-0384-6","volume":"8","author":"Y Ardeshirpour","year":"2018","unstructured":"Ardeshirpour, Y., Sackett, D. L., Knutson, J. R., & Gandjbakhche, A. H. (2018). Using in vivo fluorescence lifetime imaging to detect HER2-positive tumors. EJNMMI Research, 8(1), 26.","journal-title":"EJNMMI Research"},{"issue":"1","key":"1611_CR64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41598-024-83961-9","volume":"15","author":"I Kundacina","year":"2025","unstructured":"Kundacina, I., Schobesberger, S., Kittler, S., Thumfart, H., Spadiut, O., Ertl, P., Kne\u017eevi\u0107, N. \u017d, & Radonic, V. (2025). A versatile gold leaf immunosensor with a novel surface functionalization strategy based on protein L and trastuzumab for HER2 detection. Scientific Reports, 15(1), 34.","journal-title":"Scientific Reports"},{"key":"1611_CR65","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jim.2017.09.002","volume":"451","author":"S Tian","year":"2017","unstructured":"Tian, S., Zeng, K., Yang, A., Wang, Q., & Yang, M. (2017). A copper based enzyme-free fluorescence ELISA for HER2 detection. Journal of Immunological Methods, 451, 78\u201382.","journal-title":"Journal of Immunological Methods"},{"key":"1611_CR66","doi-asserted-by":"publisher","first-page":"124560","DOI":"10.1016\/j.talanta.2023.124560","volume":"260","author":"F Yao","year":"2023","unstructured":"Yao, F., Wang, Z. G., Liu, S. L., Wang, H., Zhu, J., He, R., & Wu, J. K. (2023). Purified fluorescent nanohybrids based on quantum dot\u2013HER2\u2013antibody for breast tumor target imaging. Talanta, 260, 124560.","journal-title":"Talanta"},{"issue":"7","key":"1611_CR67","doi-asserted-by":"publisher","first-page":"100164","DOI":"10.1016\/j.modpat.2023.100164","volume":"36","author":"Y Hu","year":"2023","unstructured":"Hu, Y., Jones, D., Zhao, W., Tozbikian, G., Wesolowski, R., Parwani, A. V., et al. (2023). Incidence, clinicopathologic features, HER2 fluorescence in situ hybridization profile, and oncotype DX results of human epidermal growth factor receptor 2-low breast cancers: Experience from a single academic center. Modern Pathology, 36(7), 100164.","journal-title":"Modern Pathology"},{"key":"1611_CR68","doi-asserted-by":"publisher","first-page":"126852","DOI":"10.1016\/j.talanta.2024.126852","volume":"281","author":"PS Pakchin","year":"2025","unstructured":"Pakchin, P. S., Fathi, F., Samadi, H., & Adibkia, K. (2025). Recent advances in receptor-based optical biosensors for the detection of multiplex biomarkers. Talanta, 281, 126852.","journal-title":"Talanta"},{"key":"1611_CR69","doi-asserted-by":"publisher","first-page":"119870","DOI":"10.1016\/j.cca.2024.119870","volume":"562","author":"A Rezabakhsh","year":"2024","unstructured":"Rezabakhsh, A., Fathi, F., Habtemariam, S., & Ahmadian, E. (2024). Cardiorenal syndrome: Plasmonic biosensors. Clinica Chimica Acta, 562, 119870.","journal-title":"Clinica Chimica Acta"},{"key":"1611_CR70","doi-asserted-by":"publisher","first-page":"134509","DOI":"10.1016\/j.molstruc.2022.134509","volume":"1274","author":"M Johari-Ahar","year":"2023","unstructured":"Johari-Ahar, M., Abdian, M., Maleki, S., Abbasgolizadeh, P., & Fathi, F. (2023). Intercalation of anticancer drug mitoxantrone into DNA: Studied by spectral and surface plasmon resonance methods. Journal of Molecular Structure, 1274, 134509.","journal-title":"Journal of Molecular Structure"},{"issue":"4","key":"1611_CR71","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s11468-022-01615-w","volume":"17","author":"A Alijani","year":"2022","unstructured":"Alijani, A., Fathi, F., Nejati, K., & Rashidi, M. R. (2022). Protective effect of crocin on endothelial cells integrity: Studied by surface plasmon resonance. Plasmonics, 17(4), 1369\u20131378.","journal-title":"Plasmonics"},{"key":"1611_CR72","doi-asserted-by":"publisher","first-page":"100034","DOI":"10.1016\/j.snr.2021.100034","volume":"3","author":"S Ji","year":"2021","unstructured":"Ji, S., Esmaeilzadeh, H., Su, J., Pagsuyoin, S., & Sun, H. (2021). Novel analysis of a micropillar coupled acoustic wave sensor. Sensors and Actuators Reports, 3, 100034.","journal-title":"Sensors and Actuators Reports"},{"issue":"8","key":"1611_CR73","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00604-025-07292-w","volume":"192","author":"X Zhang","year":"2025","unstructured":"Zhang, X., Jiao, Y., Yang, T., Xu, Z., Shao, Y., Hou, J., et al. (2025). Rapid HER2-positive cell detection via high-voltage electroosmotic flow-driven microfluidic SPRi. Microchimica Acta, 192(8), 505.","journal-title":"Microchimica Acta"},{"issue":"2","key":"1611_CR74","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1021\/acsbiomaterials.1c01369","volume":"8","author":"N Shahbazi","year":"2022","unstructured":"Shahbazi, N., Zare-Dorabei, R., & Naghib, S. M. (2022). Design of a ratiometric plasmonic biosensor for herceptin detection in HER2-positive breast cancer. ACS Biomaterials Science & Engineering., 8(2), 871\u2013879.","journal-title":"ACS Biomaterials Science & Engineering."},{"issue":"1","key":"1611_CR75","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/bios14010015","volume":"14","author":"X Wu","year":"2023","unstructured":"Wu, X., Wang, Y., Zhang, J., Zhang, Y., Rao, X., Chen, C., Liu, H., Deng, Y., Liao, C., Smietana, M. J., & Chen, G. Y. (2023). A D-shaped polymer optical fiber surface plasmon resonance biosensor for breast cancer detection applications. Biosensors, 14(1), 15.","journal-title":"Biosensors"},{"key":"1611_CR76","doi-asserted-by":"publisher","first-page":"133561","DOI":"10.1016\/j.snb.2023.133561","volume":"382","author":"O Rusyakina","year":"2023","unstructured":"Rusyakina, O., Geernaert, T., Loyez, M., Lobry, M., Chah, K., Mergo, P., et al. (2023). Cascaded Bragg gratings in photonic crystal fiber for plasmonic cladding mode-based biosensing of HER2 protein. Sensors and Actuators B: Chemical, 382, 133561.","journal-title":"Sensors and Actuators B: Chemical"},{"issue":"1","key":"1611_CR77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/bios14010015","volume":"14","author":"X Wu","year":"2023","unstructured":"Wu, X., Wang, Y., Zhang, J., Zhang, Y., Rao, X., Chen, C., et al. (2023). A D-shaped polymer optical fiber surface plasmon resonance biosensor for breast cancer detection applications. Biosensors, 14(1), 15.","journal-title":"Biosensors"},{"key":"1611_CR78","doi-asserted-by":"publisher","first-page":"109808","DOI":"10.1016\/j.intimp.2023.109808","volume":"116","author":"S Tang","year":"2023","unstructured":"Tang, S., Zhang, X., Duan, Z., Xu, M., Kong, M., Zheng, S., et al. (2023). The novel hepatoprotective mechanisms of silibinin-phospholipid complex against d-GalN\/LPS-induced acute liver injury. International Immunopharmacology, 116, 109808.","journal-title":"International Immunopharmacology"},{"issue":"3","key":"1611_CR79","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1021\/acs.bioconjchem.9b00787","volume":"31","author":"Y Guo","year":"2020","unstructured":"Guo, Y., Liu, F., Hu, Y., Zheng, X., Cao, X., Zhu, Y., et al. (2020). Activated plasmonic nanoaggregates for dark-field in situ imaging for HER2 protein imaging on cell surfaces. Bioconjugate Chemistry, 31(3), 631\u2013638.","journal-title":"Bioconjugate Chemistry"},{"key":"1611_CR80","doi-asserted-by":"publisher","first-page":"109963","DOI":"10.1016\/j.microc.2024.109963","volume":"199","author":"L Rahmidar","year":"2024","unstructured":"Rahmidar, L., Gumilar, G., Septiani, N. L. W., Wulandari, C., Iqbal, M., Wustoni, S., et al. (2024). Label-free and early detection of HER2 breast cancer biomarker based on UiO-66-NH2 modified gold chip (Au\/UiO-66-NH2) using surface plasmon resonance technique. Microchemical Journal., 199, 109963.","journal-title":"Microchemical Journal."},{"key":"1611_CR81","doi-asserted-by":"publisher","first-page":"114850","DOI":"10.1016\/j.bios.2022.114850","volume":"220","author":"L Bai","year":"2023","unstructured":"Bai, L., Gu, C., Liu, J., Gai, P., & Li, F. (2023). Photofuel cell-based self-powered biosensor for HER2 detection by integration of plasmonic-metal\/conjugated molecule hybrids and electrochemical sandwich structure. Biosensors & Bioelectronics, 220, 114850.","journal-title":"Biosensors & Bioelectronics"},{"issue":"5","key":"1611_CR82","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3390\/mi14051086","volume":"14","author":"K Erol","year":"2023","unstructured":"Erol, K., Hasabnis, G., & Altintas, Z. (2023). A novel NanoMIP\u2013SPR sensor for the point-of-care diagnosis of breast cancer. Micromachines, 14(5), 1086.","journal-title":"Micromachines"},{"issue":"4","key":"1611_CR83","doi-asserted-by":"publisher","first-page":"045206","DOI":"10.1088\/1361-6528\/28\/4\/045206","volume":"28","author":"JP Monteiro","year":"2016","unstructured":"Monteiro, J. P., Predabon, S. M., Bonaf\u00e9, E. G., Martins, A. F., Brolo, A. G., Radovanovic, E., et al. (2016). SPR platform based on image acquisition for HER2 antigen detection. Nanotechnology, 28(4), 045206.","journal-title":"Nanotechnology"},{"key":"1611_CR84","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.bios.2018.06.050","volume":"117","author":"T Wu","year":"2018","unstructured":"Wu, T., Yan, T., Zhang, X., Feng, Y., Wei, D., Sun, M., et al. (2018). A competitive photoelectrochemical immunosensor for the detection of diethylstilbestrol based on an Au\/UiO-66 (NH2)\/CdS matrix and a direct Z-scheme Melem\/CdTe heterojunction as labels. Biosensors & Bioelectronics, 117, 575\u2013582.","journal-title":"Biosensors & Bioelectronics"},{"issue":"1","key":"1611_CR85","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s12951-021-01210-x","volume":"19","author":"W Chen","year":"2021","unstructured":"Chen, W., Li, Z., Cheng, W., Wu, T., Li, J., Li, X., et al. (2021). Surface plasmon resonance biosensor for exosome detection based on reformative tyramine signal amplification activated by molecular aptamer beacon. Journal of Nanobiotechnology, 19(1), 450.","journal-title":"Journal of Nanobiotechnology"},{"issue":"9","key":"1611_CR86","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1364\/BOE.401200","volume":"11","author":"M Lobry","year":"2020","unstructured":"Lobry, M., Loyez, M., Chah, K., Hassan, E. M., Goormaghtigh, E., DeRosa, M. C., et al. (2020). HER2 biosensing through SPR-envelope tracking in plasmonic optical fiber gratings. Biomedical Optics Express, 11(9), 4862\u20134871.","journal-title":"Biomedical Optics Express"},{"issue":"11","key":"1611_CR87","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1039\/D4SD00241E","volume":"3","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Zhao, X., Liao, M., Ke, G., & Zhang, X. B. (2024). Point-of-care biosensors and devices for diagnostics of chronic kidney disease. Sensors & Diagnostics, 3(11), 1789\u20131806.","journal-title":"Sensors & Diagnostics"},{"key":"1611_CR88","doi-asserted-by":"publisher","first-page":"116743","DOI":"10.1016\/j.bios.2024.116743","volume":"267","author":"SG Chavan","year":"2025","unstructured":"Chavan, S. G., Rathod, P. R., Koyappayil, A., Hwang, S., & Lee, M. H. (2025). Recent advances of electrochemical and optical point-of-care biosensors for detecting neurotransmitter serotonin biomarkers. Biosensors and Bioelectronics, 267, 116743.","journal-title":"Biosensors and Bioelectronics"},{"key":"1611_CR89","doi-asserted-by":"publisher","first-page":"127397","DOI":"10.1016\/j.talanta.2024.127397","volume":"285","author":"P Lingadharini","year":"2025","unstructured":"Lingadharini, P., & Maji, D. J. T. (2025). Eco-sustainable point-of-care devices: Progress in paper and fabric based electrochemical and colorimetric biosensors. Talanta, 285, 127397.","journal-title":"Talanta"},{"key":"1611_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.talo.2025.100519","author":"OG Hussein","year":"2025","unstructured":"Hussein, O. G., Mahmoud, A. M., Mouhamed, A. A., Dou, Y., Nian, Q., & Safwat, N. (2025). Arduino-based portable point-of-care colorimetric glucose biosensor using nanozyme with enhanced peroxidase-like activity. Talanta Open. https:\/\/doi.org\/10.1016\/j.talo.2025.100519","journal-title":"Talanta Open"},{"key":"1611_CR91","doi-asserted-by":"publisher","first-page":"126803","DOI":"10.1016\/j.talanta.2024.126803","volume":"281","author":"YD Banguera-Ordo\u00f1ez","year":"2025","unstructured":"Banguera-Ordo\u00f1ez, Y. D., Sena-Torralba, A., Quintero-Campos, P., Maquieira, \u00c1., & Morais, S. J. T. (2025). Smartphone-based lateral flow immunoassay for sensitive determination of lactate dehydrogenase at the point of care. Talanta, 281, 126803.","journal-title":"Talanta"},{"issue":"40","key":"1611_CR92","doi-asserted-by":"publisher","first-page":"27167","DOI":"10.1021\/acsnano.4c06564","volume":"18","author":"S Liu","year":"2024","unstructured":"Liu, S., Liao, Y., Shu, R., Sun, J., Zhang, D., Zhang, W., et al. (2024). Evaluation of the multidimensional enhanced lateral flow immunoassay in point-of-care nanosensors. ACS Nano, 18(40), 27167\u201327205.","journal-title":"ACS Nano"},{"key":"1611_CR93","doi-asserted-by":"publisher","first-page":"120345","DOI":"10.1016\/j.cca.2025.120345","volume":"574","author":"BAC Jacob","year":"2025","unstructured":"Jacob, B. A. C., Songsungthong, W., Leartsakulpanich, U., & Boonyuen, U. (2025). Rapid and reliable detection of G6PD mutations using recombinase polymerase amplification coupled with lateral flow strip. Clinica Chimica Acta, 574, 120345.","journal-title":"Clinica Chimica Acta"},{"key":"1611_CR94","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.cca.2018.11.020","volume":"488","author":"Y Huang","year":"2019","unstructured":"Huang, Y., Zhang, S., Zheng, Q., Li, Y., Yu, L., Wu, Q., et al. (2019). Development of up-converting phosphor technology-based lateral flow assay for quantitative detection of serum PIVKA-II: Inception of a near-patient PIVKA-II detection tool. Clinica Chimica Acta, 488, 202\u2013208.","journal-title":"Clinica Chimica Acta"},{"key":"1611_CR95","doi-asserted-by":"publisher","first-page":"343588","DOI":"10.1016\/j.aca.2024.343588","volume":"1338","author":"S Cheng","year":"2025","unstructured":"Cheng, S., Luo, L., Bao, M., Bao, T., Gao, Y., Wu, Z., Zhang, X., Wang, S., & Wen, W. (2025). A dual-mode colorimetric\/photothermal lateral flow biosensor based on Au\/Ti3C2TX for HIV-DNA detection. Analytica Chimica Acta, 1338, 343588.","journal-title":"Analytica Chimica Acta"},{"key":"1611_CR96","doi-asserted-by":"publisher","first-page":"113471","DOI":"10.1016\/j.ab.2019.113471","volume":"588","author":"V Ranganathan","year":"2020","unstructured":"Ranganathan, V., Srinivasan, S., Singh, A., & DeRosa, M. C. (2020). An aptamer-based colorimetric lateral flow assay for the detection of human epidermal growth factor receptor 2 (HER2). Analytical biochemistry, 588, 113471.","journal-title":"Analytical biochemistry"},{"key":"1611_CR97","doi-asserted-by":"publisher","first-page":"113116","DOI":"10.1016\/j.bios.2021.113116","volume":"180","author":"S Rauf","year":"2021","unstructured":"Rauf, S., Ait Lahcen, A., Aljedaibi, A., Beduk, T., de Oliveira Filho, J. I., & Salama, K. N. (2021). Gold nanostructured laser-scribed graphene: A new electrochemical biosensing platform for potential point-of-care testing of disease biomarkers. Biosensors and Bioelectronics, 180, 113116.","journal-title":"Biosensors and Bioelectronics"},{"issue":"13","key":"1611_CR98","doi-asserted-by":"publisher","first-page":"2307262","DOI":"10.1002\/smll.202307262","volume":"20","author":"R Kim","year":"2024","unstructured":"Kim, R., Mun, B., Lim, S., Park, C., Kim, J., Lim, J., & Haam, S. (2024). Colorimetric detection of HER2-overexpressing-cancer-derived exosomes in mouse urine using magnetic-polydiacetylene nanoparticles. Small (Weinheim an der Bergstrasse, Germany), 20(13), 2307262.","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"issue":"6","key":"1611_CR99","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1021\/acsmaterialslett.4c00497","volume":"6","author":"Q Liang","year":"2024","unstructured":"Liang, Q., Zhou, Q., Yang, J., Han, Y., Pan, Y., Zhu, S., Shi, H., & Li, G. (2024). Assembly of peptide with dye molecules for the fabrication of colorimetric biosensor with application to diagnose HER2-positive breast cancer. ACS Materials Letters, 6(6), 2136\u20132143.","journal-title":"ACS Materials Letters"},{"issue":"1","key":"1611_CR100","doi-asserted-by":"publisher","first-page":"21792","DOI":"10.1038\/s41598-023-48838-3","volume":"13","author":"F Hakimian","year":"2023","unstructured":"Hakimian, F., & Mazloum-Ardakani, M. (2023). Ag nanorod@ PEI-Ag nanohybrid as an excellent signal label for sensitive and rapid detection of serum HER2. Scientific Reports, 13(1), 21792.","journal-title":"Scientific Reports"},{"issue":"6","key":"1611_CR101","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/bios15060386","volume":"15","author":"H-H Wan","year":"2025","unstructured":"Wan, H.-H., Chiang, C.-C., Ren, F., Tsai, C.-T., Chou, Y.-S., Chiu, C.-W., et al. (2025). A high-sensitivity, bluetooth-enabled PCB biosensor for HER2 and CA15-3 protein detection in saliva: A rapid, non-invasive approach to breast cancer screening. Biosensors, 15(6), 386.","journal-title":"Biosensors"},{"key":"1611_CR102","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41523-021-00290-0","volume":"7","author":"D Joh","year":"2021","unstructured":"Joh, D., Heggestad, J., Zhang, S., & Anderson, G. (2021). Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspirates. NPJ Breast Cancer, 7, 85.","journal-title":"NPJ Breast Cancer"},{"issue":"3","key":"1611_CR103","doi-asserted-by":"publisher","first-page":"e00599","DOI":"10.1002\/smtd.202500599","volume":"10","author":"HJ Choi","year":"2026","unstructured":"Choi, H. J., Park, S. Y., Song, M., Chang, J., Kim, Y., Park, H., Cha, C. D., Yang, S., Heo, N. H., Song, M. J., & Kim, D. S. (2026). Improving HER2 diagnostics with digital real-time PCR for ultrafast, precise prediction of Anti-HER2 therapy response in patients with breast cancer. Small methods, 10(3), e00599.","journal-title":"Small methods"},{"key":"1611_CR104","doi-asserted-by":"publisher","DOI":"10.34133\/2022\/9831521","author":"R Zeng","year":"2022","unstructured":"Zeng, R., Li, Y., Li, Y., Wan, Q., Huang, Z., Qiu, Z., & Tang, D. (2022). Smartphone-based photoelectrochemical immunoassay with Co9S8@ ZnIn2S4 for point-of-care diagnosis of breast cancer biomarker. Research. https:\/\/doi.org\/10.34133\/2022\/9831521","journal-title":"Research"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-026-01611-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-026-01611-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-026-01611-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:02:54Z","timestamp":1789264974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-026-01611-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":104,"alternative-id":["1611"],"URL":"https:\/\/doi.org\/10.1007\/s12033-026-01611-z","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}